Latest filing published 22 Sept 2026 for Cipher Pharmaceuticals Inc., €176k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Craig Mull in Cipher Pharmaceuticals Inc. Over a trading history stretching from 8 August 2019 to 18 September 2026, the count stands at 16 filings.
On the open market, the record shows 1 purchase worth €176k and 1 sale worth €176k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant and 13 option exercises. 2026 to date brings 1 purchase and 1 sale.
On 22 September 2026 came the latest disclosure, an open-market purchase for €176k in Cipher Pharmaceuticals Inc. The median gap between a trade and its publication by SEDI is 4 days. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations